Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients

Abstract Circulating tumor cells (CTC) are prognostic in metastatic breast cancer (MBC). The CTC-endocrine therapy index (CTC-ETI), consisting of CTC-ER (estrogen receptor), BCL2, human epidermal growth factor receptor (HER2), and Ki67 expression, might predict resistance to endocrine therapy (ET) i...

Cijeli opis

Bibliografski detalji

Glavni autori:	Costanza Paoletti, Meredith M. Regan, Samuel M. Niman, Emily M. Dolce, Elizabeth P. Darga, Minetta C. Liu, P. Kelly Marcom, Lowell L. Hart, John W. Smith, Karen L. Tedesco, Eitan Amir, Ian E. Krop, Angela M. DeMichele, Pamela J. Goodwin, Margaret Block, Kimberly Aung, Martha E. Brown, Robert T. McCormack, Daniel F. Hayes
Format:	Artigo
Jezik:	Inglês
Izdano:	Nature Portfolio 2021-06-01
Serija:	npj Breast Cancer
Online pristup:	https://doi.org/10.1038/s41523-021-00281-1
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!